Abstract
Tenofovir is a nucleotide reverse transcriptase inhibitor for treatment of human immunodeficiency virus (HIV) infection. Several cases of renal failure associated with tenofovir therapy recently have been reported. A 54-year-old man with HIV experienced decreasing renal function and Fanconi's syndrome secondary to tenofovir therapy. His condition gradually improved after discontinuation of the drug. The available medical literature for reported cases of tenofovir-related nephrotoxicity indicates that this complication is apparently rare. However, our case report and literature review underscore the importance of monitoring renal function when treating patients with any nucleotide reverse transcriptase inhibitor.
MeSH terms
-
Acquired Immunodeficiency Syndrome / complications
-
Acquired Immunodeficiency Syndrome / diagnosis
-
Acquired Immunodeficiency Syndrome / drug therapy
-
Acute Kidney Injury / chemically induced*
-
Acute Kidney Injury / complications
-
Acute Kidney Injury / diagnosis
-
Adenine / adverse effects*
-
Adenine / analogs & derivatives*
-
Adenine / therapeutic use
-
Anti-HIV Agents / therapeutic use
-
Clinical Chemistry Tests / methods
-
Fanconi Syndrome / chemically induced
-
Fanconi Syndrome / complications
-
Fanconi Syndrome / diagnosis
-
Female
-
Humans
-
Male
-
Middle Aged
-
Organophosphonates*
-
Organophosphorus Compounds / adverse effects*
-
Organophosphorus Compounds / therapeutic use
-
Reverse Transcriptase Inhibitors / adverse effects
-
Reverse Transcriptase Inhibitors / therapeutic use
-
Stavudine / therapeutic use
-
Tenofovir
-
Time Factors
-
Treatment Outcome
Substances
-
Anti-HIV Agents
-
Organophosphonates
-
Organophosphorus Compounds
-
Reverse Transcriptase Inhibitors
-
Tenofovir
-
Stavudine
-
Adenine